Maintenance reality: Plan to stay on Retatrutide long-term
Jensterle M, Kravos NA, Goricar K, Janez A (2017) Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
Early clinical trial data, most notably from the Phase 2 trial published in the New England Journal of Medicine (Jastreboff et al., 2023), demonstrated that retatrutide produced substantial reductions in body weight up to approximately 24% over 48 weeks at the highest doses studied
The trade-offs: higher cost, less dose flexibility, and dependence on manufacturer supply
Together, well review your medical history and goals to create a program tailored to your needs